Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors

Background. Anti-PD1/PDL1 immune checkpoint inhibitors (ICIs) showed promising results in breast cancer, and exploration of additional actionable immune checkpoints is ongoing. Inflammatory breast cancer (IBC) is an aggressive form of disease, the immune tumor microenvironment (TME) of which is poor...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncoimmunology
Main Authors: Bertucci, François, Boudin, Laurys, Finetti, Pascal, Van Berckelaer, Christophe, Van Dam, Peter, Dirix, Luc, Viens, Patrice, Gonçalves, Anthony, Ueno, Naoto T., Van Laere, Steven, Birnbaum, Daniel, Mamessier, Emilie
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis 2021
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8158040/
https://ncbi.nlm.nih.gov/pubmed/34104544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1929724
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker